salvage surgery

PROCEDURE9 trials

Sponsors

Clinica Universidad de Navarra, Universidad de Navarra, First Affiliated Hospital, Sun Yat-Sen University, Ohio State University Comprehensive Cancer Center, Sun Yat-sen University, Eye & ENT Hospital of Fudan University

Conditions

AdenocarcinomaCervical CancerClinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Effects of ChemotherapyGastric CancerGastrointestinal NeoplasmsHead and Neck Carcinoma of Unknown Primary

Phase 1

Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer

RecruitingNCT04754321

Ohio State University Comprehensive Cancer CenterHead and Neck Carcinoma of Unknown Primary, Locally Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma +3

Start: 2022-05-12End: 2026-12-31Target: 45Updated: 2026-02-02

Phase 2

Tirelizumab Plus Surgery vs Surgery Alone for Recurrent Nasopharyngeal Carcinoma

Eye & ENT Hospital of Fudan UniversityNasopharyngeal Carcinoma

Start: 2021-10-20End: 2024-10-20Target: 80Updated: 2021-10-25

TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial

Not yet recruitingNCT06987123

Sun Yat-sen UniversityNasopharyngeal Carcinoma (NPC)

Start: 2025-05-18End: 2029-06-01Target: 62Updated: 2025-05-23

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

RecruitingNCT07195734

National Cancer Institute (NCI)Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Locally Recurrent Head and Neck Squamous Cell Carcinoma +15

Start: 2026-10-09End: 2033-02-01Target: 180Updated: 2026-04-03

Phase 3

Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma

RecruitingNCT04778956

Sun Yat-sen UniversityNasopharyngeal Carcinoma, PD-1, Surgery

Start: 2021-03-03End: 2033-03-03Target: 218Updated: 2021-03-04

Unknown Phase

Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients

CompletedNCT02454647

Clinica Universidad de Navarra, Universidad de NavarraAdenocarcinoma, Effects of Chemotherapy, Gastric Cancer +2

Start: 2013-09-30End: 2015-03-31Updated: 2015-05-28

Analysis of the Curative Effect of Salvage Surgery on Recurrent Laryngeal Carcinoma

CompletedNCT03604601

First Affiliated Hospital, Sun Yat-Sen UniversityRecurrent Laryngeal Carcinoma

Start: 2016-06-01End: 2018-06-01Updated: 2018-07-27

The Efficacy of Salvage Surgery in Patients With Residual Tumor After Concurrent Chemoradiation for Locally Advanced Cervical Cancer.

RecruitingNCT05749887

Chongqing University Cancer HospitalCervical Cancer

Start: 2023-08-25End: 2032-12-31Target: 188Updated: 2023-10-10

Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal Cancer

Cancer Institute and Hospital, Chinese Academy of Medical SciencesLocally Recurrent Colorectal Cancer

Start: 2023-01-30End: 2025-12-31Target: 500Updated: 2023-11-02

Related Papers

Tislelizumab as adjuvant therapy following endoscopic surgery for resectable recurrent nasopharyngeal carcinoma: A phase 2 randomized clinical trial.

Journal of Clinical Oncology2025-05-28

Tislelizumab as adjuvant therapy following endoscopic surgery for resectable recurrent nasopharyngeal carcinoma: a randomized clinical trial

Journal for ImmunoTherapy of Cancer2025-05-011 citations